Xi'an Tianmei's Stachyose Standards Aim to Break China's Premium Prebiotic Bottleneck

Xi'an Tianmei's Two-Decade Push to Standardise Stachyose

Stachyose is a naturally occurring tetrasaccharide found in plants such as Chinese artichoke (Stachys sieboldii). Because it reaches the large intestine intact, it is widely used as a prebiotic that selectively feeds bifidobacteria, putting it at the centre of a fast-growing Chinese market for gut-health foods, infant formula and special-medical-purpose foods.

Xi'an Tianmei Biotechnology Co., Ltd., active in functional oligosaccharides since 2006, is trying to turn that position into something more durable: market rule-making. The company says it holds 14 invention patents and 53 registered trademarks, and has built a full-chain production platform covering extraction, purification and removal of heavy metals and salts. It claims its manufacturing already meets European and North American market requirements.

Tianmei's central move is standardisation. It says it led the drafting of an industry standard for measuring stachyose in food using nuclear magnetic resonance (NMR) spectroscopy, a molecular-level method intended to settle long-standing disputes over true content and purity. It also led the drafting of T/CCCMHPIE1.39-2018, a trade standard for plant-extract stachyose that defines technical indicators, testing methods, packaging, storage and traceability, and codifies the commonly used purity grades P70, P80 and P90.

The commercial logic is straightforward. According to the company, P80 and above grades have used the standards to pass qualification for special-medical and infant-formula channels, while P70 is positioned for ordinary functional foods — turning a previously vague specification into a price ladder. The article is a company-focused feature rather than independent reporting, so these claims should be read as Tianmei's account unless independently confirmed.

Rule-Setting as a Moat: What Tianmei's Standards Really Change

The source material is promotional in nature: a state-affiliated finance outlet republishing what is effectively a corporate narrative. Beneath that, the substance is a real strategic question — can a mid-sized Chinese ingredient maker use standard-setting to capture pricing power in a niche market where international suppliers have historically defined the rules?

One Standard, Two Meanings

The code T/CCCMHPIE1.39-2018 matters. The T/ prefix identifies a Chinese group or trade-chamber standard, in this case linked to the China chamber of commerce that covers medicines and health products imports and exports. That makes it an export-relevant commercial reference, not an ISO-level international norm and not a mandatory national standard. The feature styles it an 'international business standard'; in practice, its international weight depends entirely on whether overseas regulators and formulators choose to recognise it.

Purity Grades as a Price Ladder

By codifying P70, P80 and P90, Tianmei is converting an ambiguous specification into defined market tiers. P80 and above aim at the high-margin, barrier-regulated segments — infant formula and special-medical foods — where scrutiny on purity and traceability is strictest. P70 stays in the crowded functional-food space. The unverified but critical claim is that standard endorsement has actually secured high-end market qualification for Tianmei's own P80+ product lines; that is the difference between a marketing frame and a commercial reality.

A Small Market With Outsize Margins

The headline figures are modest. Market researcher QYR is cited putting China's food-grade stachyose market at about 11,000 tonnes in 2025 and the global market at US$183 million by 2032. Those numbers sit beneath far larger umbrellas — domestic prebiotic and probiotic food and beverage sales above RMB 5.5 billion a year and a gut-health functional food market approaching RMB 60 billion. The prize is not volume; it is access to premium, regulated segments and the pricing power that comes with them.

Who Gains, Who Loses

If Tianmei's account holds, the main winners are downstream formulators — dairies, special-medical-food developers and health brands gain a standardised NMR-based quality control method that cuts screening and verification costs. High-purity domestic producers gain an alternative route into premium channels that previously defaulted to international-sourced ingredients. The losers are low-purity price-cutters, whose material can now be rejected against a written specification, and, more slowly, international suppliers whose certification regimes face a competing Chinese reference point in third markets. If the standards are not recognised by importing regulators, the market-access claims remain promotional rather than enforceable.

How Buyers and Rivals Should Read Tianmei's Purity Grades

The standards described are only useful if market participants actually write them into contracts and quality control. For the parties this story touches:

• Downstream formulators in infant formula, special-medical foods and dairy: specify the purity grade (P70, P80 or P90) and the NMR detection method in incoming-material contracts, so supplier claims can be checked against a defined measuring protocol.
• Domestic stachyose producers: treat T/CCCMHPIE1.39-2018 as the baseline for export documentation; material below P80 is likely stranded in lower-margin functional food channels if Tianmei's stated access claims prove accurate.
• Overseas buyers of Chinese plant extracts: verify with their own regulators whether the chamber standard and NMR test method satisfy local import requirements — this is a trade-body norm, not a mandatory international rule.
• Competitors and investors: watch whether Chinese food-safety authorities adopt the NMR method into national supervision; that would convert a company-led standard into an industry-wide compliance requirement and materially change the playing field.